| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 93 |
| 1 | OMEPRAZOLE MAGNESIUM | 81 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 67 |
| 3 | TACROLIMUS OINTMENT 0.1% | 67 |
| 4 | KETAMINE HYDROCHLORIDE | 63 |
| 5 | ADALIMUMAB | 62 |
| 6 | MYCOPHENOLATE MOFETIL | 56 |
| 7 | OMEPRAZOLE | 55 |
| 8 | OLANZAPINE PAMOATE | 51 |
| 9 | ACETAMINOPHEN | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | KETAMINE HYDROCHLORIDE | 63 | 0.0123 |
| 1 | ETHIODIZED OIL | 8 | 0.0062 |
| 2 | ETRASIMOD | 4 | 0.0024 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 7 | 0.0015 |
| 4 | OLANZAPINE PAMOATE | 51 | 0.0012 |
| 5 | URSODIOL | 24 | 0.0011 |
| 6 | SODIUM FLUORIDE | 4 | 0.0011 |
| 7 | URSOSIOL | 21 | 0.0011 |
| 8 | VALGANCICLOVIR | 14 | 0.0007 |
| 9 | CHOLESTYRAMINE | 8 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 125 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 102 |
| 2 | Proton Pump Inhibitor [EPC] | 79 |
| 3 | Atypical Antipsychotic [EPC] | 74 |
| 4 | Benzodiazepine [EPC] | 69 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 64 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 52 |
| 7 | Kinase Inhibitor [EPC] | 51 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 50 |
| 9 | Platinum-based Drug [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 2 | beta Lactamase Inhibitor [EPC] | 7 | 0.0016 |
| 3 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 4 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 5 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 6 | Bile Acid [EPC] | 25 | 0.0011 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 8 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 64 | 0.0006 |